Literature DB >> 26354339

Challenges of Pre- and Post-Test Counseling for Orthodox Jewish Individuals in the Premarital Phase.

E Rose1,2, N Schreiber-Agus3,4, K Bajaj5, S Klugman5,3, T Goldwaser5,3.   

Abstract

The Jewish community has traditionally taken ownership of its health, and has taken great strides to raise awareness about genetic issues that affect the community, such as Tay-Sachs disease and Hereditary Breast and Ovarian Cancer syndrome. Thanks in part to these heightened awareness efforts, many Orthodox Jewish individuals are now using genetics services as they begin to plan their families. Due to unique cultural and religious beliefs and perceptions, the Orthodox Jewish patients who seek genetic counseling face many barriers to a successful counseling session, and often seek the guidance of programs such as the Program for Jewish Genetic Health (PJGH). In this article, we present clinical vignettes from the PJGH's clinical affiliate, the Reproductive Genetics practice at the Montefiore Medical Center. These cases highlight unique features of contemporary premarital counseling and screening within the Orthodox Jewish Community, including concerns surrounding stigma, disclosure, "marriageability," the use of reproductive technologies, and the desire to include a third party in decision making. Our vignettes demonstrate the importance of culturally-sensitive counseling. We provide strategies and points to consider when addressing the challenges of pre- and post-test counseling as it relates to genetic testing in this population.

Entities:  

Keywords:  Genetic counseling; Genetics; Jewish law; Orthodox Jewish

Mesh:

Year:  2015        PMID: 26354339     DOI: 10.1007/s10897-015-9880-2

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  17 in total

1.  The Dor Yeshorim story: community-based carrier screening for Tay-Sachs disease.

Authors:  J Ekstein; H Katzenstein
Journal:  Adv Genet       Date:  2001       Impact factor: 1.944

2.  "The Most Important Test You'll Ever Take"?: attitudes toward confidential carrier matching and open individual testing among modern-religious Jews in Israel.

Authors:  Ayala Frumkin; Aviad E Raz; Morasha Plesser-Duvdevani; Sari Lieberman
Journal:  Soc Sci Med       Date:  2011-10-19       Impact factor: 4.634

3.  Genetic counseling for the orthodox jewish couple undergoing preimplantation genetic diagnosis.

Authors:  B E David; G A Weitzman; C Hervé; M Fellous
Journal:  J Genet Couns       Date:  2012-04-25       Impact factor: 2.537

4.  Do medical models of mental illness relate to increased or decreased stigmatization of mental illness among orthodox Jews?

Authors:  Steven Pirutinsky; Daniel D Rosen; Rachel Shapiro Safran; David H Rosmarin
Journal:  J Nerv Ment Dis       Date:  2010-07       Impact factor: 2.254

Review 5.  Carrier testing for Ashkenazi Jewish disorders in the prenatal setting: navigating the genetic maze.

Authors:  Jose Carlos P Ferreira; Nicole Schreiber-Agus; Suzanne M Carter; Susan Klugman; Anthony R Gregg; Susan J Gross
Journal:  Am J Obstet Gynecol       Date:  2014-02-05       Impact factor: 8.661

Review 6.  Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis.

Authors:  R Akolekar; J Beta; G Picciarelli; C Ogilvie; F D'Antonio
Journal:  Ultrasound Obstet Gynecol       Date:  2015-01       Impact factor: 7.299

7.  Tay-Sachs disease--carrier screening, prenatal diagnosis, and the molecular era. An international perspective, 1970 to 1993. The International TSD Data Collection Network.

Authors:  M Kaback; J Lim-Steele; D Dabholkar; D Brown; N Levy; K Zeiger
Journal:  JAMA       Date:  1993-11-17       Impact factor: 56.272

8.  Carrier matching and collective socialization in community genetics: Dor Yeshorim and the reinforcement of stigma.

Authors:  Aviad E Raz; Yafa Vizner
Journal:  Soc Sci Med       Date:  2008-08-11       Impact factor: 4.634

9.  The clinical content of preconception care: genetics and genomics.

Authors:  Benjamin D Solomon; Brian W Jack; W Gregory Feero
Journal:  Am J Obstet Gynecol       Date:  2008-12       Impact factor: 8.661

Review 10.  Cancer risks among BRCA1 and BRCA2 mutation carriers.

Authors:  E Levy-Lahad; E Friedman
Journal:  Br J Cancer       Date:  2007-01-15       Impact factor: 7.640

View more
  3 in total

1.  Understanding Factors Associated with Uptake of BRCA1/2 Genetic Testing among Orthodox Jewish Women in the USA Using a Mixed-Methods Approach.

Authors:  Meghna S Trivedi; Hilary Colbeth; Haeseung Yi; Alejandro Vanegas; Rebecca Starck; Wendy K Chung; Paul S Appelbaum; Rita Kukafka; Isaac Schechter; Katherine D Crew
Journal:  Public Health Genomics       Date:  2019-06-04       Impact factor: 2.000

2.  Attitudes and interest in incorporating BRCA1/2 cancer susceptibility testing into reproductive carrier screening for Ashkenazi Jewish men and women.

Authors:  Melanie W Hardy; Beth N Peshkin; Esther Rose; Mary Kathleen Ladd; Savannah Binion; Mara Tynan; Colleen M McBride; Karen A Grinzaid; Marc D Schwartz
Journal:  J Community Genet       Date:  2022-04-29

3.  Young Israeli women with epithelial ovarian cancer: prevalence of BRCA mutations and clinical correlates.

Authors:  Limor Helpman; Omri Zidan; Eitan Friedman; Sarit Kalfon; Tamar Perri; Gilad Ben-Baruch; Jacob Korach
Journal:  J Gynecol Oncol       Date:  2017-06-05       Impact factor: 4.401

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.